Gastrointestinal adverse events Very common (10% or more): Diarrhea (35%), abdominal pain (21%), vomiting (21%), nausea (12%) Common (1% to 10%): Constipation, dyspepsia, gastrointestinal disorder, melena Very rare (less than 0.01%): Abdominal cramps [Ref] Nervous system Very common (10% or more): Headache (37%), dizziness (18%), paresthesia (12%) Common (1% to 10%): Hypertonia, vertigo, taste perversion Frequency not reported : Seizures (with or without pre-existing seizure activity), increase in seizure frequency and/or severity [Ref] Metabolic Very common (10% or more): Hypercalcemia (15%), hypervolemia (12%) Common (1% to 10%): Anorexia, hyperkalemia [Ref] There are reports from clinical trials of significant hypertriglyceridemia associated with high doses of levocarnitine (3 g/day) given to uremic dialysis patients
Cancel early, and you can lose most of the savings
While previous medications only targeted one or two pathways, Retatrutide targets the "Triple G" Pathway: GLP-1: Controls hunger and slows digestion
Your healthcare provider will help you choose the best option based on factors like: Your medical history and current health status Your weight loss goals Your risk of potential side effects Your insurance coverage and ability to access the medication The availability of compounded versions, which may offer cost savings However, its always important to discuss the pros and cons of compounded medications with your healthcare provider
Novo Nordisk also manufactures Wegovy
Summary So, now you know exactly what to look for when choosing the right supplement for acne